Welcome to LookChem.com Sign In|Join Free

CAS

  • or

607-31-8

Post Buying Request

607-31-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

607-31-8 Usage

Uses

4-Methoxyquinoline is used as a reactant in the synthesis of hybrid quinoline-4-yloxadiazoles/oxathiadiazoles as potent antifungal agents.

Check Digit Verification of cas no

The CAS Registry Mumber 607-31-8 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 6,0 and 7 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 607-31:
(5*6)+(4*0)+(3*7)+(2*3)+(1*1)=58
58 % 10 = 8
So 607-31-8 is a valid CAS Registry Number.
InChI:InChI=1/C10H9NO/c1-12-10-6-7-11-9-5-3-2-4-8(9)10/h2-7H,1H3

607-31-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-Methoxyquinoline

1.2 Other means of identification

Product number -
Other names 4-methoxy-4(1H)quinolon

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:607-31-8 SDS

607-31-8Relevant articles and documents

Structure and synthesis of echinorin, an alkaloid from Echinops ritro L. and sphaerocephalus L. (Asteraceae)

Schr?der,Luckner

, p. 39 - 46 (1968)

-

-

Moodie et al.

, p. 1493,1494,1496,1497 (1971)

-

Discovery of MK-8318, a Potent and Selective CRTh2 Receptor Antagonist for the Treatment of Asthma

Huang, Xianhai,Brubaker, Jason,Zhou, Wei,Biju, Purakkattle J.,Xiao, Li,Shao, Ning,Huang, Ying,Dong, Li,Liu, Zhidan,Bitar, Rema,Buevich, Alexei,Jung, Joon,Peterson, Scott L.,Butcher, John W.,Close, Joshua,Martinez, Michelle,Maccoss, Rachel N.,Zhang, Hongjun,Crawford, Scott,McCormick, Kevin D.,Aslanian, Robert,Nargund, Ravi,Correll, Craig,Gervais, Francois,Qiu, Hongchen,Yang, Xiaoxin,Garlisi, Charles,Rindgen, Diane,Maloney, Kevin M.,Siliphaivanh, Phieng,Palani, Anandan

supporting information, p. 679 - 684 (2018/07/05)

A novel series of tricyclic tetrahydroquinolines were identified as potent and selective CRTh2 receptor antagonists. The agonism and antagonism switch was achieved through structure-based drug design (SBDD) using a CRTh2 receptor homologue model. The challenge of very low exposures in pharmacokinetic studies was overcome by exhaustive medicinal chemistry lead optimization through focused SAR studies on the tricyclic core. Further optimization resulted in the identification of the preclinical candidate 4-(cyclopropyl((3aS,9R,9aR)-7-fluoro-4-(4-(trifluoromethoxy)benzoyl)-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]quinolin-9-yl)amino)-4-oxobutanoic acid (15c, MK-8318) with potent and selective CRTh2 antagonist activity and a favorable PK profile suitable for once daily oral dosing for potential treatment of asthma.

PYRAZOLE DERIVATIVES AS MALT1 INHIBITORS

-

, (2018/07/05)

Disclosed are compounds, compositions and methods for treating of diseases, syndromes, conditions, and disorders that are affected by the modulation of MALT1. Such compounds are represented by Formula (I) as follows: wherein R1, R2, R3, R4, R5, R6, R5, G1, and G2 are defined herein.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 607-31-8